The Walgreens Boots Alliance deal with primary-care company VillageMD will be rolled out over the next three to five years
New York — Walgreens Boots Alliance plans to open as many as 700 doctors’ offices in its drugstores over the next five years and invest $1bn in primary-care provider VillageMD over the next three, the company said on Wednesday.
Drugstores are under pressure to re-invent themselves as e-commerce companies such as Amazon gobble up sales of everyday items, and digital pharmacies threaten the prescription drug business. Walgreens, based in Illinois, intends to open between 500 and 700 Village Medical clinics over the next five years in more than 30 markets, with more than 50% of the sites located in areas designated as medically under-served. The size will vary, though most will occupy about 25% of the store’s footprint, Gourlay said.
Clinics will be installed in stores where pharmacy sales tend to be strong and sales of products in the front of the store, such as toothpaste and sweets, lag, Gourlay said. The five pilot locations have seen rising prescription and health-product purchases while sales of convenience items fell, he said.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Walgreens to put 700 doctors in pharmacies with $1bn investmentThe Walgreens Boots Alliance deal with primary-care company VillageMD will be rolled out over the next three to five years
Read more »
Walgreens to put 700 doctors in pharmacies with $1bn investmentThe Walgreens Boots Alliance deal with primary-care company VillageMD will be rolled out over the next three to five years
Read more »
Reserve Bank takes up R5.1bn in government bonds in JuneThe June purchases were roughly half of what was bought in May
Read more »
Reserve Bank halves government bond purchases in JuneThe central bank launched the bond buying programme to inject liquidity into the financial system
Read more »
Tribunal slaps Dis-Chem with R1.2m fine for inflating face mask pricesThe Competition Commission accused Dis-chem of abusing its dominance and charging excessive prices for surgical masks to the detriment of customers and consumers. Dis-chem denied the commission’s claims.
Read more »
Dis-Chem ordered to pay R1.2m fine for 'reprehensible' mask price hikesThe Competition Tribunal has fined Dis-Chem Pharmacies R1.2m after finding the company guilty of charging excessive prices for surgical face masks during the Covid-19 pandemic.
Read more »